Cardinal Health, Inc. $CAH Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund

Key Points

• The Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in Cardinal Health, Inc. by 6.7% during the first quarter, bringing its total holdings to 56,017 shares valued at approximately $7.7 million.
• JPMorgan Chase & Co. significantly increased its position in Cardinal Health by 40.0%, now owning over 4.1 million shares, while institutional investors collectively own 87.17% of the stock.
• Cardinal Health reported a quarterly earnings per share of $2.08, exceeding consensus estimates, but had a revenue of $60.16 billion, which fell short of expectations.

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 56,017 shares of the company's stock after purchasing an additional 3,500 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in Cardinal Health were worth $7,717,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. JPMorgan Chase & Co. increased its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Northern Trust Corp increased its position in Cardinal Health by 16.2% during the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock worth $359,286,000 after purchasing an additional 422,755 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Cardinal Health by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock worth $274,599,000 after purchasing an additional 94,768 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Cardinal Health by 3.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company's stock worth $189,390,000 after purchasing an additional 55,781 shares during the last quarter. Finally, Castlekeep Investment Advisors LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $141,963,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Up 2.4%

Shares of Cardinal Health stock traded up $3.6280 during trading hours on Wednesday, hitting $152.6480. The company's stock had a trading volume of 2,522,918 shares, compared to its average volume of 2,420,015. The company has a market capitalization of $36.45 billion, a PE ratio of 23.67, a P/E/G ratio of 1.26 and a beta of 0.67. The business has a fifty day moving average of $159.46 and a 200 day moving average of $144.99. Cardinal Health, Inc. has a 1-year low of $106.54 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health's dividend payout ratio is 31.63%.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 235,775 shares of company stock valued at $35,102,939. Corporate insiders own 0.09% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CAH. Evercore ISI dropped their price target on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research report on Wednesday, August 13th. Robert W. Baird increased their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. UBS Group reissued a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Leerink Partners dropped their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $163.20.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.